[ad_1]
At the start of the new year, cryptocurrency traders are certainly full of hope that 2019 will be more bullish than last year. C & # 39; was an article I read a few days ago that exposed some really strong reasons why traders should be optimistic about the cryptocurrency in 2019. The logic is solid. And while diversified cryptographic portfolios are always the best bet, traders may want to do Encrypgen (DNA) a large part of their wallets. I expect DNA to be one of the most performing token of 2019.
Strong commercial session
In the last six months, I have written a lot about Encrypgen because I believe that society has significant potential. And now, with the new year on us, it seems that other traders are finally catching on. DNA exploded almost 50% on one of the biggest volume days in recent history. The coin has since been traced but is still increasing by about 30% (at the time of writing this document).
This is particularly significant because of the large sales wall that had been in place for weeks. A large token holder had to leave the position for personal reasons. And those tokens are now held in strong hands that believe in the project. Now that the sales wall has broken, DNA hackers can expect significant growth, both in business and in the symbolic price.
Encrypgen Team focused on business growth
Although not true for many cryptographic projects, Encrypgen has focused on the core business regardless of the price of the token. In December, Encrypgen announced a partnership with Murrieta Genomics. This could be an invaluable collaboration as Encrypgen continues to see increased genomic data sets loaded into the gene chain.
In addition to working to convince consumers to upload their genomic data sets, Encrypgen is also making sure that researchers join the platform. For a real market to occur, it is obviously necessary to have buyers and sellers. On the gene chain, consumers are the sellers and the researchers are the buyers. Researchers will use DNA tokens to purchase data directly from consumers. This volume is what will ultimately drive the symbolic price of DNA. The vision is that Encrypgen becomes Amazon.com of genomic data.
Future developments in 2019
As the company continues to progress, token holders can expect significant developments throughout the rest of the year. Some of these expected developments include:
- Additional partnerships
- Risk capital financing
- Growth of genomic data
- New exchange lists
There is no doubt that cryptocurrency can sometimes be a game of momentum. And now with the recent increase in the DNA business, Encrypgen seems to have a significant boost. The question will be whether the company can maintain it.
DNA token hodlers can expect to see a flurry of news that will emerge in the coming weeks and beyond. Many of these announcements will focus on additional partnerships that will help drive the company's core business. Beyond that, the company is securing additional funding from a venture capital agreement. If a VC agreement is completed, it could have a significant impact on the price of the token. As the company advances, it will also be important to keep an eye on the growth signals of the number of genomic data sets that consumers have loaded into the gene chain. The more sets are available, the more transactions will occur between consumers and researchers.
Finally, but probably less important, will be the news concerning the new exchanges. Encrypgen maintains its position that it will not pay bribes to have its own token listed in the exchanges. And this is certainly the right decision. But, hopefully, the big legitimate exchanges like Bittrex will see the potential of the DNA token and show it. If that happens, it would be an advantage for the price of the DNA token.
Conclusion
Encrypgen remains the first position in my portfolio. Although 2018 was a difficult year, I certainly expect it to change over the next 12 months. And while I expect many altcoins to participate in a crypt rally, I expect DNA to be the best ever.
Disclosure: Chris has a long position in DNA
Featured image courtesy of Shutterstock.
